Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Lowe

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Colorectal Cancer|March 2, 2020
Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients' Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology CentersGeorge Kafatos, Sabada Dube, Peter Burdon, et al.
Virchows Archiv : an International Journal of Pathology|February 6, 2019
European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projectsCleo Keppens, Kelly Dufraing, Han J van Krieken, et al.
Plos One|December 7, 2007
Effects of blood collection conditions on ovarian cancer serum markersJason D Thorpe, Xiaobo Duan, Robin Forrest, et al.
Breast Cancer Research and Treatment|June 1, 2012
Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White womenKerryn W Reding, Christopher S Carlson, Orsalem Kahsai, et al.
Cancer Causes & Control : CCC|March 16, 2012
Estrogen-related genes and their contribution to racial differences in breast cancer riskKerryn W Reding, Chu Chen, Kimberly Lowe, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Colorectal Cancer|March 2, 2020
Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients' Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology CentersGeorge Kafatos, Sabada Dube, Peter Burdon, et al.
Virchows Archiv : an International Journal of Pathology|February 6, 2019
European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projectsCleo Keppens, Kelly Dufraing, Han J van Krieken, et al.
Plos One|December 7, 2007
Effects of blood collection conditions on ovarian cancer serum markersJason D Thorpe, Xiaobo Duan, Robin Forrest, et al.
Breast Cancer Research and Treatment|June 1, 2012
Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White womenKerryn W Reding, Christopher S Carlson, Orsalem Kahsai, et al.
Cancer Causes & Control : CCC|March 16, 2012
Estrogen-related genes and their contribution to racial differences in breast cancer riskKerryn W Reding, Chu Chen, Kimberly Lowe, et al.
Pageof 2